Why continued surveillance? Intermittent blood pressure and heart rate abnormality under treatment

Biomed Pharmacother. 2005 Oct;59 Suppl 1(Suppl 1):S141-51. doi: 10.1016/s0753-3322(05)80022-8.

Abstract

Several opinion leaders have monitored their blood pressure systematically a sufficient number of times a day for chronomic (time structural) analyses, from the time of encountering chronobiology until their death; they set an example for others who also may not wish to base treatment on single spotchecks in a health care office. Such self-measurements, while extremely helpful, were not readily feasible without a noteworthy interruption of activities during waking as well as of sleep. New, relatively unobtrusive instrumentation now makes monitoring possible and cost-effective and will save lives. Illustrative results and problems encountered in an as-one-goes self-survey by GSK, a physician-scientist, are presented herein. Both MESOR-hypertension and CHAT (circadian hyper-amplitude-tension) can be intermittent conditions even under treatment, and treatment is best adjusted based on monitoring, rather than "flying blind".

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use
  • Blood Pressure / drug effects
  • Blood Pressure / physiology*
  • Circadian Rhythm / physiology
  • Heart Rate / drug effects
  • Heart Rate / physiology*
  • Humans
  • Hypertension / drug therapy
  • Hypertension / physiopathology
  • Male
  • Monitoring, Physiologic
  • Periodicity
  • Risk Factors

Substances

  • Antihypertensive Agents